Protein kinase Cγ antibodies and paraneoplastic cerebellar degeneration

Journal of Neuroimmunology

Volumn 256, Issue 1-2, 2013, Pages 91-93

  Höftberger, Romana ^a,b   Kovacs, Gabor G ^c   Sabater, Lidia ^a,b   Nagy, Peter ^d   Racz, Gergely ^d   Miquel, Rosa ^b   Dalmau, Josep ^e,f   Graus, Francesc ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d SEMMELWEIS UNIVERSITY   (Hungary)

^e HOSPITAL CLÍNIC   (Spain)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adenocarcinoma; Onconeural antibodies; Paraneoplastic cerebellar degeneration; PKC gamma

Indexed keywords

CANCER ANTIBODY; CYTOKERATIN 20; PROTEIN KINASE C GAMMA; PROTEIN KINASE C GAMMA ANTIBODY; UNCLASSIFIED DRUG;

AGED; ANTIBODY DETECTION; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CEREBELLAR ATAXIA; CYTOPLASM; DENDRITE; DYSARTHRIA; DYSDIADOCHOKINESIA; DYSKINESIA; FEMALE; GALLBLADDER CARCINOMA; HISTOPATHOLOGY; HUMAN; IMMUNOBLOTTING; IMMUNOREACTIVITY; NERVE FIBER; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURKINJE CELL; SCREENING TEST; STORAGE TEMPERATURE;

AGED; ANIMALS; ANTIBODIES; FEMALE; HIPPOCAMPUS; HUMANS; KERATIN-20; PARANEOPLASTIC CEREBELLAR DEGENERATION; PROTEIN KINASE C; PURKINJE CELLS; RATS;

EID: 84875364267     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.12.002     Document Type: Article

References (17)

1. Aboul-Enein F., Höftberger R., Buxhofer-Ausch V., Drlicek M., Lassmann H., Budka H., Kristoferitsch W. Neocortical neurones may be targeted by immune attack in anti-Yo paraneoplastic syndrome. Neuropathol. Appl. Neurobiol. 2008, 34:248-252.
2. Albert M.L., Darnell J.C., Bender A., Francisco L.M., Bhardwaj N., Darnell R.B. Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat. Med. 1998, 4:1321-1324.
3. Bataller L., Sabater L., Saiz A., Serra C., Claramonte B., Graus F. Carbonic anhydrase-related protein VIII: autoantigen in paraneoplastic cerebellar degeneration. Ann. Neurol. 2004, 56:575-579.
4. Franz M.G., Norman J.G., Fabri P.J., Gower W.R. Differentiation of pancreatic ductal carcinoma cells associated with selective expression of protein kinase C isoforms. Ann. Surg. Oncol. 1996, 3:564-569.
5. Graus F., Saiz A., Dalmau J. Antibodies and neuronal autoimmune disorders of the CNS. J. Neurol. 2010, 257:509-517.
6. Hammack J.E., Kimmel D.W., O'Neill B.P., Lennon V.A. Paraneoplastic cerebellar degeneration: a clinical comparison of patients with and without Purkinje cell cytoplasmic antibodies. Mayo Clin. Proc. 1990, 65:1423-1431.
7. Höftberger R., Dalmau J., Graus F. Clinical neuropathology practice guide 5-2012: updated guideline for the diagnosis of antineuronal antibodies. Clin. Neuropathol. 2012, 31:337-341.
8. Hug H., Sarre T.F. Protein kinase C isoenzymes: divergence in signal transduction?. Biochem. J. 1993, 291(Pt 2):329-343.
9. Jarius S., Wandinger K.P., Horn S., Heuer H., Wildemann B. A new Purkinje cell antibody (anti-Ca) associated with subacute cerebellar ataxia: immunological characterization. J. Neuroinflammation 2010, 7:21.
10. Kamimura K., Hojo H., Abe M. Characterization of expression of protein kinase C isozymes in human B-cell lymphoma: relationship between its expression and prognosis. Pathol. Int. 2004, 54:224-230.
11. Kuranami M., Powell C.T., Hug H., Zeng Z., Cohen A.M., Guillem J.G. Differential expression of protein kinase C isoforms in human colorectal cancers. J. Surg. Res. 1995, 58:233-239.
12. Lin S.Y., Liang Y.C., Ho Y.S., Tsai S.H., Pan S., Lee W.S. Involvement of both extracellular signal-regulated kinase and c-jun N-terminal kinase pathways in the 12-O-tetradecanoylphorbol-13-acetate-induced upregulation of p21(Cip1) in colon cancer cells. Mol. Carcinog. 2002, 35:21-28.
13. Martiny-Baron G., Fabbro D. Classical PKC isoforms in cancer. Pharmacol. Res. 2007, 55:477-486.
14. Mazzoni E., Adam A., Bal de Kier Joffe E., Aguirre-Ghiso J.A. Immortalized mammary epithelial cells overexpressing protein kinase C gamma acquire a malignant phenotype and become tumorigenic in vivo. Mol. Cancer Res. 2003, 1:776-787.
15. Sabater L., Bataller L., Carpentier A.F., Aguirre-Cruz M.L., Saiz A., Benyahia B., Dalmau J., Graus F. Protein kinase Cgamma autoimmunity in paraneoplastic cerebellar degeneration and non-small-cell lung cancer. J. Neurol. Neurosurg. Psychiatry 2006, 77:1359-1362.
16. Saito N., Shirai Y. Protein kinase C gamma (PKC gamma): function of neuron specific isotype. J. Biochem. 2002, 132:683-687.
17. Way K.J., Chou E., King G.L. Identification of PKC-isoform-specific biological actions using pharmacological approaches. Trends Pharmacol. Sci. 2000, 21:181-187.